Viewing Study NCT06393660

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-05-01 @ 5:19 AM
Study NCT ID: NCT06393660
Status: AVAILABLE
Last Update Posted: 2025-10-14
First Post: 2024-04-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)
Sponsor: Victor Aquino
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Transplant-Related Disorder View
None GVH - Graft Versus Host Reaction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TCR Alpha/Beta View
None CliniMACS View